Oxford University vaccine | The Business Standard

A healthcare worker shows a vial and a box of the AstraZeneca coronavirus disease (COVID-19) vaccine, as vaccinations resume after a brief pause in their use over concern for possible connection to blood clots, in Turin, Italy, March 19, 2021. REUTERS/Massimo Pinca

Coronavirus chronicle

AstraZeneca vaccine 79% effective in US trial

Many European countries have resumed using the shot in their inoculation programmes after a regional regulator said it was safe

Photo: Collected

Coronavirus chronicle

Oxford University to test Covid-19 vaccine response among children for first time

Sample from patients are analysed as part of the trial. Photo: BBC.

Coronavirus chronicle

Oxford scientists preparing vaccine versions to combat emerging virus variants

Britain's Medicines and Healthcare products Regulatory Agency (MHRA) started an accelerated "rolling review" of the vaccine at the start of this month as data comes in on safety and efficacy. Photo: Reuters

Coronavirus chronicle

Oxford vaccine can be 90% effective, results show

Coronavirus chronicle

WHO says vaccine safety top priority, as AstraZeneca pauses study

File Photo: Small bottles labelled with a "Vaccine Covid-19" sticker and a medical syringe are seen in this illustration taken April 10, 2020. Reuters/Dado Ruvic/Illustration/File Photo

Coronavirus chronicle

Vaccine candidates from India progressing well, says ICMR